Biotech · Private company · Columbia, MO, US
Shift Pharmaceuticals Holdings, Inc.
Track this companyFree. Adds Shift Pharmaceuticals Holdings, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Anti-sense oligonucleotide inhibitors of retinoic acid signaling and reversion of retinal remodeling for mitigating vision lossFiscal year 2026 · $37.1KNIH RePORTER 5R41EY036319-02 · fetched Nov 12, 2026
- Anti-sense oligonucleotide inhibitors of retinoic acid signaling and reversion of retinal remodeling for mitigating vision lossFiscal year 2025 · $312.2KNIH RePORTER 1R41EY036319-01A1 · fetched Nov 12, 2026